Pharmacy Program

The Power of Your Choice

Your choice of the IHTC Pharmacy Program directly supports your IHTC team and patient services, and activities provided to the hemophilia community. The IHTC Pharmacy Program provides savings to you and your health insurance plan.

Every patient has the right to choose their clotting factor pharmacy provider. The IHTC supports your right of choice and will assist you in making an informed decision.

Patient Family 1.jpg

Sickle Cell Disease Resources

The IHTC is involved a variety of research studies to better understand the complications of sickle cell disease. It is our hope that this research will allow the medical community at large to develop treatments to prevent or minimize complications, prolong and improve the quality of life for those with sickle cell disease.

If you are interested in participating in a research study, please let a member of our healthcare team know.

Resources for Patients and Families

Presentations from 2015 Indiana Sickle Cell Conference
April 24, 2015

Russell Ware, MD, PhD
Hydroxyurea for Providers

Kimber Blackwell, MPAS, PA-C
Sickle Cell Disease: Managing Acute & Chronic Complications in Adults

Did you like this? Share it: